Halozyme(CH:RV7)
CHF 101.900.00 (0.00%)
CH:RV7
Halozyme earnings date
CHF 101.90
At close:0.00 (0.00%)
Halozyme (RV7) Q2 2026 Earnings Report
0 Followers
CH:RV7 Q2 2026 EPS Results
- Actual EPS
- CHF 1.92
- Consensus EPS
- CHF 1.51
- Beat/Miss
- Beat by +CHF 0.42
- One Year Ago EPS
- CHF 1.30
CH:RV7 Q2 2026 Revenue Results
- Actual Revenue
- CHF 405.81M
- Expected Revenue
- CHF 339.40M
- Beat/Miss
- Beat by +CHF 66.41M
- YoY Revenue Growth
- +47.67%
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 08/06/2026
- Time
- After Close
- Conference Call
- Thursday, August 6, 2026
CH:RV7 Upcoming Earnings
Halozyme's next earnings date is estimated for February 23, 2027, based on past reporting schedules.
Q2 2026 Earnings Call Audio
CH:RV7 Q2 2026 Earnings Call
0:00 / 0:00
Q2 2026 Earnings Slide Deck
Q2 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
CH:RV7 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 23, 2027 | 2026 (Q4) | 2.16- | -0.2 | ― | ― |
| Nov 05, 2026 | 2026 (Q3) | 1.942.02 | 1.45 | 38.95% (+0.57) | |
| Aug 06, 2026 | 2026 (Q2) | 1.511.92 | 1.3 | 48.05% (+0.62) | |
| May 11, 2026 | 2026 (Q1) | 1.301.35 | 0.94 | 44.14% (+0.41) | |
| Feb 17, 2026 | 2025 (Q4) | 1.85-0.20 | 1.06 | -119.05% (-1.27) | |
| Nov 03, 2025 | 2025 (Q3) | 1.381.45 | 1.07 | 35.43% (+0.38) | |
| Aug 05, 2025 | 2025 (Q2) | 1.071.30 | 0.77 | 69.23% (+0.53) | |
| May 06, 2025 | 2025 (Q1) | 0.800.94 | 0.67 | 40.51% (+0.27) | |
| Feb 18, 2025 | 2024 (Q4) | 0.981.06 | 0.69 | 53.66% (+0.37) | |
| Oct 31, 2024 | 2024 (Q3) | 0.841.07 | 0.63 | 69.33% (+0.44) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed


